title: The management of immunosuppression in patients with inflammatory bowel disease and cancer.
authors.affiliation: The Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, , New York, New York, USA.
authors.forename: Oren
authors.initials: O
authors.lastname: Bernheim
authors.forename: Jean-Frederic
authors.initials: JF
authors.lastname: Colombel
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Ullman
authors.forename: David
authors.initials: D
authors.lastname: Laharie
authors.forename: Laurent
authors.initials: L
authors.lastname: Beaugerie
authors.forename: Steven H
authors.initials: SH
authors.lastname: Itzkowitz
mesh_terms: D000075202:Contraindications; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy*; D009369:Neoplasms / Q000150:complications* / Q000276:immunology; D011687:Purines / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D007166:Immunosuppressive Agents; D011687:Purines; D014409:Tumor Necrosis Factor-alpha
keywords: CANCER; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; TNF; ULCERATIVE COLITIS